Publication | Closed Access

Treatment of acute myeloid leukemia and blastic phase of chronic myeloid leukemia with combined eflornithine (alpha difluoromethylornithine) and methylglyoxal-bis-guanyl hydrazone (methyl-GAG)

Hematological MalignancyChronic Myeloid LeukemiaOncologyMethylglyoxal-bis-guanyl HydrazoneMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMetronomic TherapyPharmacologyPharmacotherapyAnti-cancer AgentMedicineCancer ResearchDrug DiscoveryMyeloid Neoplasia